http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6d00d3aba027043e0cfebb59b17c883
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Kantarjian Hagop M. Kantarjian |
| name | Hagop M Kantarjian Hagop M. Kantarjian |
| given-name | Hagop M. Hagop M |
| organization-name | Department of Leukemia, at the University of Texas M.D. Anderson Cancer Centec, Houston, TX, 77030, USA Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, TX Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston Departments of Leukemia The University of Texas MD Anderson Cancer Center Houston TX USA M. D. Anderson Cancer Center, Houston, TX; and From the Departments of Bioimmunotherapy, Hematopathology, and Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Johnson & Johnson Pharmaceutical Research and Development, Titusville, NJ, and Beerse, Belgium. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA From the Departments of Bioimmunotherapy, Hematology, and Biomathematics, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; From the Departments of Leukemia, Bioimmunotherapy, and Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston. The University of Texas MD Anderson Cancer Center, Houston, TX; and Josephine Ford Cancer Institute, Brownstown Charter Township, MI The University of Texas MD Anderson Cancer Center, Houston, TX; 38Department of Leukemia, MD Anderson Cancer Center, Houston, TX University of Texas MD Anderson Cancer Center Houston Texas Chair, Leukemia Department, and Professor of Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. University of Texas MD, Anderson Cancer Center Houston TX USA From the Departments of Hematopathology, Biostatistics, and Leukemia, The University of Texas MD Anderson Cancer Center, Houston. Department of Leukemia at The University of Texas M. D. Anderson Cancer Center, Houston, Texas. Departments ofLeukemia and 1The Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. Kathryn G. Roberts, Zhaohui Gu, Debbie Payne-Turner, Kelly McCastlain, Deqing Pei, Ilaria Iacobucci, Marcus Valentine, Stanley B. Pounds, Lei Shi, Yongjin Li, Jinghui Zhang, Cheng Cheng, and Charles G. Mullighan, St Jude Children’s Research Hospital, Memphis, TN; Richard C. Harvey, I-Ming Chen, and Cheryl L. Willman, University of New Mexico Cancer Center, Albuquerque, NM; Alessandro Rambaldi, Manuela Tosi, and Orietta Spinelli, Ospedale Papa Giovanni XXIII, Bergamo, Italy; Jerald P. Radich, Fred... Department of Leukemia Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston Texas Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA From the University of Texas M. D. Anderson Cancer Center, Houston; US Oncology, San Antonio, TX; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Penn State Hershey Medical Center, Hershey, PA; Emory University School of Medicine, Atlanta, GA; Oregon Health and Science University Center, Portland, OR; Mount Sinai School of Medicine, New York, NY; West Virginia University Hospital, Morgantown, WV; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA;... From the Departments of LeukemiaBiomathematics, and Radiotherapy, M.D. Anderson Cancer Center, Houston, TX; and Department of Hematology and Oncology, Children’s Memorial Hospital of Chicago, Chicago, IL. Department of Leukemia, MD Anderson Cancer Center, Houston, United States From University of Texas M.D. Anderson Cancer Center, Houston, Texas, and Oregon Health Sciences University, Portland, Oregon. From the Departments of Leukemia and Hematopathology, M.D. Anderson Cancer Center, Houston, TX. Ruben A. Mesa, Mayo Clinic, Scottsdale, AZ; Jason Gotlib, Stanford Cancer Institute, Stanford, CA; Vikas Gupta, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; John V. Catalano, Frankston Hospital and Monash University, Frankston, Victoria, Australia; Michael W. Deininger, Oregon Health and Science University, Portland, OR, and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Alan L. Shields, Adelphi Values, Boston, MA; Carol B. Miller, Saint Agnes Cancer... Department of Leukemia Division of Cancer Medicine MD Anderson Cancer Center University of Texas Houston Texas 1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. From the Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston. Department of Leukemia University of Texas M. D. Anderson Cancer Center Houston TX Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX From the Department of Leukemia, University of Texas, M.D. Anderson Cancer Center, Houston, TX; the Department of Hematopathology, University of Texas, M.D. Anderson Cancer Center, Houston, TX; and the Department of Biostatistics, University of Texas, M.D. Anderson Cancer Center, Houston, TX. Authors' Affiliations: 1The University of Texas, M.D. Anderson Cancer Center, Houston, Texas;2University of Bologna, “L. e A. Seràgnoli,” Bologna, Italy;3University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy From the Department of Leukemia and the Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX. From the Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; and Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. From the Departments of Leukemia and Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX. Department of Leukemia University of Texas, MD Anderson Cancer Center Houston Texas USA Department of Leukemia, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA Department of Leukemia, MD Anderson Cancer Center The University of Texas Houston Texas USA From the Departments of Leukemia and of Biostatistics and Applied Mathematics, The University of Texas MD Anderson Cancer Center, Houston, TX; and the Nichols Institute, Quest Diagnostics, San Juan Capistrano, CA. From the Department of Leukemia and the Department of Bioimmunotherapy, The University of Texas M. D. Anderson Cancer Center, Houston, TX. All authors: University of Texas MD Anderson Cancer Center, Houston, TX. 1Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, Texas and From the University of Texas M. D. Anderson Cancer Center, Houston, TX. From the Departments of Leukemia, Bioimmunotherapy,Biostatistics, and Blood and Bone Marrow Transplantation,M.D. Anderson Cancer Center, Houston, TX; and the National CancerInstitute, Bethesda, MD. The University of Texas M. D. Anderson Cancer Center, Houston, TX; Department of Hematology, The University of Texas M. D. Anderson Cancer Center, Houston Authors' Affiliation: The University of Texas M. D. Anderson Cancer Center, Houston, Texas 1Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, and 2Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas Division of Cancer Medicine Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas Stefan Faderl, Farhad Ravandi, and Hagop M. Kantarjian, The University of Texas MD Anderson Cancer Center, Houston; Robert Collins, UT Southwestern Medical Center at Dallas, Dallas, TX; Meir Wetzler and Eunice S. Wang, Roswell Park Cancer Institute, Buffalo; Karen Seiter, New York Medical College, Valhalla, NY; David Rizzieri, Duke University Medical Center, Durham, NC; Gary Schiller, University of California, Los Angeles, CA; Madan Jagasia, Vanderbilt University Medical Center, Nashville, TN; Robert... Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and Authors' Affiliations: Departments of 1Lymphoma and Myeloma and 2Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas From the Departments of Leukemia and Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, TX. The University of Texas MD Anderson Cancer Center, Houston, TX Departments of Leukemia, Hematopathology, and Biostatistics, University of Texas M. D. Anderson Cancer Center, Houston and Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The University of Texas MD Anderson Cancer Center Houston Texas Division of Cancer Medicine, Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas 2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. Departments of Leukemia and Bioimmunotherapy; University of Texas M.D. Anderson Cancer Center; Houston, TX Hematology Program, Division of Laboratory Medicine, and the Department of Hematology, The University of Texas M. D. Anderson Cancer Center, and Molecular Diagnostic Associates, Inc., Houston, Texas M. D. Anderson Cancer Center, Houston, TX; The University of Texas MD Anderson Cancer Center, Houston, TX, USA, From the Departments of Leukemia and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. From the University of Texas M.D. Anderson Cancer Center, Houston (C.D.D., H.M.K.); Memorial Sloan Kettering Cancer Center (E.M.S., M.S.T.) and Weill Cornell Medical College (G.J.R.), New York; Institut Gustave Roussy, Villejuif (S.B., C.W.), and Centre Hospitalier Universitaire Bordeaux, Bordeaux (A.P.) — both in France; Northwestern University, Chicago (J.K.A.); Ohio State University Wexner Medical Center, Columbus (A.S.M.); Sylvester Comprehensive Cancer Center, University of Miami, Miami (R.S.);... All authors: The University of Texas MD Anderson Cancer, Houston, TX. Susan Branford, Centre for Cancer Biology, SA Pathology, University of Adelaide; Timothy P. Hughes, Royal Adelaide Hospital, Adelaide, Australia; Dong-Wook Kim, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, Korea; Simona Soverini and Giovanni Martinelli, University of Bologna, Bologna; Giuseppe Saglio, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy; Ariful Haque and Richard C. Woodman, Novartis, East Hanover, NJ; Yaping Shou, Novartis, Cambridge, MA; Hagop M... From the University of Texas M.D. Anderson Cancer Center, Houston, Texas; and University of Florence, Florence, Italy. 1Leukemia and Departments of The University of Texas MD Anderson Cancer Center, Houston, TX; From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA. From the Departments of Leukemia and Bioimmunotherapy, University of Texas M. D. Anderson Cancer Center, Houston, TX. Department of Leukemia, M. D. Anderson Cancer Center, Houston, Texas The University of Texas MD Anderson Cancer Center Houston TX USA From the Departments of Leukemia and Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX. From the Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston. From the Departments of Leukemia, Experimental Therapeutics, and Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX. University of Texas MD Anderson Cancer Center, Houston, TX University of Texas MD Anderson Cancer Center Houston Texas USA From the Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX; and the First Department of Internal Medicine and the Department of Molecular Biology, Cancer Research Institute, Sapporo Medical University, Sapporo, Japan. Department of Leukemia, MD Anderson Cancer Center, Houston, TX; University of Texas MD Anderson Cancer Center, Houston, TX; From the Departments of Bioimmunotherapy and Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston. From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston; and the Center for Professional Excellence, The Methodist Hospital, Houston, TX. Leukemia Department, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Leukemia University of Texas MD Anderson Cancer Center Houston Texas Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; From the Departments of Leukemia and Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Baylor College of Medicine and Michael DeBakey Veterans Administration Hospital, Houston, TX; and the Department of Pathophysiology, First Faculty of Medicine, Charles University, Prague, Czech Republic. Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston; and Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; and From the Mayo Clinic, Rochester, MN; The University of Texas, M. D. Anderson Cancer Center, Houston; and Celgene, Summit, NJ. All authors: The University of Texas MD Anderson Cancer Center, Houston, TX Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA From the Departments of Leukemia and Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston. Authors' Affiliations: 1Department of Leukemia, the University of Texas MD Anderson Cancer Center; and 2Division of Biostatistics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas Hagop M. Kantarjian, Michael Mathisen, and Leonard A. Zwelling, MD Anderson Cancer Center, Houston, TX; and Tito Fojo, National Cancer Institute, National Institutes of Health, Bethesda, MD. The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX; From the University of Texas M. D. Anderson Cancer Center, Houston, TX; University of Bologna, Instituto de Emotologia L. e A. Seràgnoli, Bologna; University of Naples, Naples, Italy; Clinical Investigation Centre 802 INSERM, CHU de Poitiers, Poitiers, France; Oregon Health Sciences University Knight Cancer Institute, Portland, OR; SA Pathology, Royal Adelaide Hospital, Adelaide, Australia; Seoul St Mary's Hospital, Catholic University of Korea, Seoul, Korea; Hospital De Clinicas De Curitiba, Parana;... From the Weill Medical College of Cornell University, New York, NY; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Pathology, University of California–San Diego; and SGX Pharmaceuticals, San Diego, CA From the Department of Leukemia, The University of Texas, M. D. Anderson Cancer Center, Houston; the Arizona Cancer Center, Tucson; the Mount Sinai Medical Center, New York, NY; the University of Rochester Medical Center, NY; the Indianapolis Community Cancer Center, IN; Sugen, South San Francisco, CA; and the University of Maryland Greenebaum Cancer Center, Baltimore, MD Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA; From the Departments of Bioimmunotherapy and Leukemia, M. D. Anderson Cancer Center, Houston, TX, and Schering-Plough Research Institute, Kenilworth, NJ. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas; Health Policies, Baker Institute at Rice University Houston Texas Department of Leukemia and 1Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX Department of Leukemia, Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston Texas a University of Texas MD Anderson Cancer Center, Houston, Texas, USA From the Department of Leukemia and Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX From the Division of Hematology/Oncology, University of California at San Francisco School of Medicine, San Francisco; University of California at Los Angeles, Los Angeles, CA; Department of Leukemia, M.D. Anderson Cancer Center, Houston; University of Texas Southwestern Medical Center, Dallas, TX; Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY; Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA; Oregon Health Science University, Portland... From the Department of Pathology, Baylor College of Medicine; and the Departments of Leukemia, Bioinformatics and Computational Biology, and Hematopathology University of Texas M. D. Anderson Cancer Center, Houston, TX. Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX From the Departments of Blood and Marrow Transplantation, Leukemia, and Hematopathology, University of Texas M. D. Anderson Cancer Center, Houston. Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA Kiyomi Morita, Hagop M. Kantarjian, Feng Wang, Yuanqing Yan, Carlos Bueso-Ramos, Koji Sasaki, Ghayas C. Issa, Sa Wang, Jeffrey Jorgensen, Xingzhi Song, Jianhua Zhang, Samantha Tippen, Rebecca Thornton, Marcus Coyle, Latasha Little, Curtis Gumbs, Naveen Pemmaraju, Naval Daver, Courtney D. DiNardo, Marina Konopleva, Michael Andreeff, Farhad Ravandi, Jorge E. Cortes, Tapan Kadia, Elias Jabbour, Guillermo Garcia-Manero, Keyur P. Patel, P. Andrew Futreal, and Koichi Takahash, The University of Texas MD... Department of Leukemia, 12Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Jorge E. Cortes and Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center, Houston, TX; Neil P. Shah, University of California San Francisco School of Medicine, San Francisco, CA; Brigid Bradley-Garelik and George Manos, Bristol-Myers Squibb, Princeton, NJ; Giuseppe Saglio, University of Turin, Turin; Michele Baccarani, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy; Jiří Mayer, University Hospital Brno and Central European Institute of Technology, Masaryk University,... From the Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston; and the Department of Bioimmunotherapy, The University of Texas M. D. Anderson Cancer Center, Houston The University of Texas MD Anderson Cancer Center, Houston, Texas, USA From the University of Texas M.D. Anderson Cancer Center, Houston, Texas. All authors: The University of Texas MD Anderson Cancer Center, Houston, TX. From the Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX; Johns Hopkins Oncology Center, Baltimore, MD; and Suire BioChem Inc, Laval, Quebec, Canada. Department of Leukemia, The University of Texas at MD Anderson Cancer Center, Houston, TX, USA; MD Anderson Cancer Center, Houston, TX From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX. Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX Departments of Leukemia, M D Anderson Cancer Center, Houston, Texas 77030, USA. [email protected] From the Departments of Bioimmunotherapy and Leukemia, The University of Texas MD Anderson Cancer Center, Houston; the Department of Internal Medicine, University of Colorado Health Science Center, Denver; the Drug Discovery Program, H. Lee Moffitt Cancer Center and Research Institute, Department of Oncology, University of South Florida, Tampa; and the National Cancer Institute, Bethesda, MD. MD Anderson Cancer Center Houston TX USA From the Mayo Clinic, Rochester, MN; M. D. Anderson Cancer Center, Houston, TX; Division of Hematology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, University of Pavia, Pavia, Italy; Weill-Cornell Medical Center, New York, NY; Medical University of Vienna, Vienna, Austria; UCLA Medical Center, Los Angeles, CA; Hospital Clinic, Institut d'Investigatacions Biomedique, University of Barcelona, Barcelona, Spain; Mayo Clinic, Jacksonville, FL; Fred Hutchinson Cancer... Department of Leukemia Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston Texas From the Leukemia Department, The University of Texas M.D. Anderson Cancer Center, Houston, TX. From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana–Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) — all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham,... From MD Anderson Cancer Center, Houston, Texas, and University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. Department of Leukemia, M. D. Anderson Cancer Center, Houston, TX; From the Departments of Leukemia and Biomathematics, The University of Texas M.D. Anderson Cancer Center, Houston; Department of Clinical Research, Institute for Drug Development, San Antonio, TX; and BioChem Pharma Inc, Laval, Quebec, Canada. From the Departments of Leukemia, Biostatistics, Lymphoma and Myeloma, Epidemiology, and Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX. Department of Leukemia, MD Anderson Cancer Center, Houston, TX;; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; MD Anderson Cancer Center, University of Texas, Houston, TX; and From the Departments of Leukemia, Biostatistics, Bone Marrow Transplantation, and Bioimmunotherapy, M.D. Anderson Cancer Center, Houston, TX. Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň,... Department of Leukemia The University of Texas M. D. Anderson Cancer Center Houston TX USA From the Departments of Hematopathology, Biostatistics, and Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX. 3Department of Leukemia, and University of Texas MD Anderson Cancer Center Houston TX USA From The University of Texas M. D. Anderson Cancer Center, Houston, TX. Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX; 2Department of Leukemia, Division of Cancer Medicine, University of Texas M. D. Anderson Cancer Center, Houston, Texas; From the Departments of Bioimmunotherapy, Molecular Oncology, and Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX. 1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX From the Departments of Leukemia and Biostatistics and Applied Mathematics, University of Texas, M. D. Anderson Cancer Center, Houston, TX; and the Department of Hematopathology, Nichols Institute, Quest Diagnostics, San Juan Capistrano, CA. Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA 4 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Leukemia, MD Anderson Cancer Center, University of Texas, Houston, TX; From the Departments of Leukemia, Experimental Therapeutics, and Breast and Head and Neck, The University of Texas M.D. Anderson Cancer Center, Houston, TX. 1MD Anderson Cancer Center, University of Texas, Houston, Texas. Department of Leukemia, and Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA From the Departments of Hematopathology and Leukemia, The University of Texas MD Anderson Cancer Center, Houston. Authors' Affiliations: 1Department of Leukemia; 2Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas; 3Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 4Division of Hematology/Department of Medicine; 5Department of Epidemiology, University of Washington, Seattle, Washington; and 6National Cancer Institute, Rockville, Maryland From the Departments of Hematopathology, Leukemia, and Biostatistics; The University of Texas M. D. Anderson Cancer Center, Houston, TX. MD Anderson Cancer Center, Houston, TX; and From the Departments of Leukemia, Hematopathology, and Bioimmunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX, and Novartis Oncology, East Hanover, NJ. From the Departments of Bioimmunotherapy and Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston 10MD Anderson Cancer Center, University of Texas, Houston, TX; Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas USA Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030 1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston TX USA From the Departments of Leukemia, Blood and Marrow Transplantation, and Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX; and Department of Leukemia the University of Texas MD Anderson Cancer Center, Texas From the Departments of Leukemia, Biostatistics, Pediatrics, and Hematopathology, University of Texas M. D. Anderson Cancer Center, Houston. The University of Texas MD Anderson Cancer Center, Houston, Texas. Departments of Leukemia and From the Departments of Leukemia, Biostatistics and Applied Mathematics, Lymphoma/Myeloma, and Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX The University of Texas M.D. Anderson Cancer Center, Houston, TX Qiushi Chen and Turgay Ayer, Georgia Institute of Technology; Christopher R. Flowers, Emory University, Atlanta, GA; Qiushi Chen and Jagpreet Chhatwal, Massachusetts General Hospital; Jagpreet Chhatwal, Harvard Medical School, Boston, MA; Nitin Jain, William G. Wierda, Michael J. Keating, and Hagop M. Kantarjian, The University of Texas MD Anderson Cancer Center, Houston, TX; and Susan M. O’Brien, University of California Irvine Medical Center, Orange, CA. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston TX USA Department of Leukemia the University of Texas MD Anderson Cancer Center Houston Texas Jorge E. Cortes and Hagop M. Kantarjian, The University of Texas MD Anderson Cancer Center, Houston, TX; Christine Powell, Pfizer, Cambridge, MA; Athena M. Countouriotis, Pfizer, La Jolla, CA; Dong-Wook Kim, Seoul St Mary's Hospital, Seoul, South Korea; Tim H. Brümmendorf, Universitäts-Klinikum Aachen, Rheinisch-Westfaelische Technische Hochschule Aachen, Aachen; Tim H. Brümmendorf, Universitäts-Klinikum Hamburg-Eppendorf, Hamburg, Germany; Irina Dyagil, Research Center for Radiation Medicine, Academy of... From the Clinical Research Division and Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center; Department of Medicine, Division of Hematology, and Division of Medical Oncology, University of Washington, Seattle, WA; Leukemia Department and Department of Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, TX; Dana Farber Cancer Institute, Boston, MA; and Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center,... Department of Leukemia University of Texas M. D. Anderson Cancer Center Houston Texas From the Department of Leukemia, Department of Biostatistics, and Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston. Departments ofLeukemia, Departments of Leukemia, From the Departments of Leukemia, Experimental Therapeutics, Phase I Program, and Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX; University of California San Diego Moore's Cancer Center, San Diego, CA; and Dana-Farber Cancer Institute, Boston, MA 3University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Leukaemia, Box 428, University of Texas MD Anderson Cancer Center, 1400 Holcombe Boulevard, Houston, TX 77030, USA Leukemia Department, University of Texas M. D. Anderson Cancer Center, Houston, TX; From the Departments of Leukemia, Blood and Marrow Transplantation, Molecular Pathology, and Bioimmunotherapy, The University of Texas MD Anderson Cancer Center, Houston. From the Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Division of Hematology, University of Southern California Keck Medical School; and Norris Cancer Center, Los Angeles, CA. Departments of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. [email protected] From the Departments of Leukemia, Bioimmunotherapy, and Molecular Pathology, University of Texas M. D. Anderson Cancer Center, Houston; and Novartis Pharmaceuticals, East Hanover, NJ. Authors' Affiliation: Department of Leukemia and Center for Cancer Epigenetics, University of Texas M. D. Anderson Cancer Center, Houston, Texas Department of Leukemia, MD Anderson Cancer Center, Houston, TX 8Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas. 7Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas. From the Departments of Leukemia, Hematopathology, Stem Cell Transplantation and Cellular Therapy, and Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Division of Hematological Malignancies, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD. Department of Leukemia, M. D. Anderson Cancer Center, Houston, TX 12Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. |
Incoming Links
Showing number of triples: 1 to 944 of 944.